Pretargeted imaging of peritoneal carcinomatosis using bioorthogonal chemistry

被引：0
|
作者：
Rondon, A. [1 ,2 ]
Ty, N. [1 ]
Bequignat, J. [1 ]
Quintana, M. [1 ]
Briat, A. [1 ]
Witkowski, T. [1 ]
Bouchon, B. [1 ]
Boucheix, C. [3 ]
Miot-Noirault, E. [1 ]
Pouget, J. [2 ]
Chezal, J. [1 ]
Navarro-Teulon, I. [2 ]
Moreau, E. [1 ]
Degoul, F. [1 ]
机构：
[1] INSERM, U1240, Clermont Ferrand, France
[2] INSERM, U1194, IRCM, Montpellier, France
[3] INSERM, U935, Villejuif, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0193
引用
收藏
页码：S512 / S512
页数：1
相关论文
共 50 条
  • [1] Pretargeted imaging using bioorthogonal chemistry in mice
    Rossin, Raffaella
    Robillard, Marc S.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2014, 21 : 161 - 169
  • [2] Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
    Rondon, Aurelie
    Schmitt, Sebastien
    Briat, Arnaud
    Ty, Nancy
    Maigne, Lydia
    Quintana, Mercedes
    Membreno, Rosemery
    Zeglis, Brian M.
    Navarro-Teulon, Isabelle
    Pouget, Jean-Pierre
    Chezal, Jean-Michel
    Miot-Noirault, Elisabeth
    Moreau, Emmanuel
    Degoul, Francoise
    THERANOSTICS, 2019, 9 (22): : 6706 - 6718
  • [3] Pretargeted Radioimmunotherapy and SPECT Imaging of Peritoneal Carcinomatosis Using Bioorthogonal Click Chemistry: Probe Selection and First Proof-of-Concept
    Degoul, F.
    Rondon, A.
    Schmitt, S.
    Briat, A.
    Ty, N.
    Quintana, M.
    Membreno, R.
    Zeglis, B.
    Navarro-Teulon, I.
    Pouget, J.
    Chezal, J.
    Miot-Noirault, E.
    Moreau, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S436 - S437
  • [4] Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry
    van de Watering, Floor C. J.
    Rijpkema, Mark
    Robillard, Marc
    Oven, Wim J. G.
    Boerman, Otto C.
    FRONTIERS IN MEDICINE, 2014, 1
  • [5] Pretargeted approach for tumor PET imaging using supramolecular nanoparticles with in vivo bioorthogonal chemistry
    Xing, Yan
    Choi, Jin-Sil
    Peng, Jinliang
    Lin, Wei-Yu
    Li, Guoquan
    Conti, Peter
    Tseng, Hsian-Rong
    Chen, Kai
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [6] Efficient synthesis and radiosynthesis of tetrazine probes for pretargeted imaging of peritoneal carcinomatosis
    Schmitt, S.
    Ty, N.
    Chezal, J.
    Canitrot, D.
    Degoul, F.
    Bequignat, J.
    Moreau, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S661 - S661
  • [7] Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy
    Knight, James C.
    Cornelissen, Bart
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 4 (02): : 96 - 113
  • [8] Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
    Chandler, Christopher S.
    Bell, Meghan M.
    Chung, Sebastian K.
    Veach, Darren R.
    Fung, Edward K.
    Punzalan, Blesida
    Vargas, Daniela Burnes
    Patel, Mitesh
    Xu, Hong
    Guo, Hong-fen
    Santich, Brian H.
    Zanzonico, Pat B.
    Monette, Sebastien
    Nash, Garrett M.
    Cercek, Andrea
    Jungbluth, Achim
    Pandit-Taskar, Neeta
    Cheung, Nai Kong, V
    Larson, Steven M.
    Cheal, Sarah M.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) : 125 - 137
  • [9] 99mTc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging
    Fernanda Garcia, Maria
    Zhang, Xiuli
    Shah, Manankumar
    Newton-Northup, Jessica
    Cabral, Pablo
    Cerecetto, Hugo
    Quinn, Thomas
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (06) : 1209 - 1215
  • [10] From Darkness to Light: Pretargeted Radionuclide Imaging Driven by Tetrazine Bioorthogonal Chemistry
    Shen, Guohua
    Liu, Zhenhua
    Ge, Baoyi
    Kuang, Anren
    Wu, Haoxing
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (18) : 1515 - 1519
12345